R&D Changing Faces: Board of Directors and Advisory Boards, Febr... Boardrooms and advisory panels across pharma, biotech, medtech, and digital health were busy last month.
Sales & Marketing Changing Faces: Agency, consultancy, and investor, February ... February was a light month for agency and consultancy news, but a few interesting changes came through.
Digital Changing Faces: Digital and supplier, February 2026 This month's round-up spans clinical trial technology, drug discovery AI, genomics, bioelectrical medicine, CDMOs, and non-profits.
R&D Changing Faces: Pharma and biotech, February 2026 The pharmaceutical and biotech sectors have seen a flurry of executive movement this month.
R&D Changing Faces: Board of Directors, January 2026 January was a relatively quiet month for Board news, but there were some notable moves here and there.
Digital Changing Faces: Digital and supplier, January 2026 The life sciences supplier and digital health sectors witnessed significant leadership movements in January.
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
